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DISPATCHES

Staphylococcus aureus Colonization and
Long-Term Risk for Death, United States
Angelico Mendy, Edgar R. Vieira,
Ahmed N. Albatineh, Janvier Gasana
To examine the association of colonization by Staphylococcus aureus and general population mortality, we followed
10,598 adults for 8.5 years on average. Methicillin-susceptible S. aureus colonization was not associated with death.
Methicillin-resistant S. aureus carriage predicted death in a
crude analysis but not after adjustment for socioeconomic
status and co-morbidities.

S

taphylococcus aureus is a common cause of mild to lifethreatening infections. It is differentiated into methicillin-susceptible S. aureus (MSSA) and methicillin-resistant
S. aureus (MRSA); the emergence of isolates resistant to
vancomycin has raised concern that the bacterium might
become untreatable with current antimicrobial drugs (1).
Whether S. aureus colonization influences general population mortality remains unclear (2,3). Therefore, we examined the association in a US population representative
sample followed for nearly a decade.
The Study
We used data from the 2001–2004 National Health
and Nutrition Examination Survey (NHANES) and the
NHANES 2001–2004 Mortality-Linked File. NHANES
is a survey of the US noninstitutionalized civilian population conducted by the Centers for Disease Control and
Prevention’s National Center for Health Statistics. We
selected 10,598 NHANES participants using a complex
multistage sampling design and followed them through
December 31, 2011, to track mortality. NHANES protocols were approved by the institutional review boards
of NCHS and CDC, and all participants provided
informed consent.
Nasal swabs collected from participants were tested
for S. aureus and methicillin resistance during 2001–2004
following the National Committee for Clinical Laboratory
Standards disk-diffusion method. We additionally tested
isolates resistant to oxacillin (MRSA) and intermediately
resistant to oxacillin and every tenth isolate sensitive to
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oxacillin (MSSA) for staphylococcal cassette chromosome mec (SCCmec) typing, genes encoding enterotoxins,
toxic shock syndrome toxin-1, and Panton-Valentine leukocidin (PVL) toxin (details on the methods are available
at http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/
l35_b_doc.pdf). We collected data on age, sex, race/ethnicity, family income, smoking, and medical conditions
using questionnaires.
Univariate and multivariate Cox proportional hazards
regressions were used to estimate the hazard ratio (HR)
with corresponding 95% CIs for MSSA and MRSA association with mortality. Analyses were performed in STATA
version 11 (StataCorp LP, College Station, TX, USA), taking into account the survey design and sampling weights, to
produce nationally representative estimates. We considered
p values <0.05 as statistically significant.
A total of 27.3% of participants were colonized with
MSSA and 1.3% with MRSA (Table 1). During an average
of 8.5 years of follow-up, the total death rate per 1,000 person-years was 10.3: 10.8 for noncolonized participants, 8.8
for those colonized with MSSA, and 25.6%for those colonized with MRSA. MRSA-colonized participants tended to
be older and non-Hispanic white, have low poverty income
ratio, smoke cigarettes, have co-morbidities, or have been
hospitalized and/or have had dialysis in the previous 12
months (Table 1). Approximately 58.6% of MRSA isolates
were of SCCmec type II, suggestive of hospital-associated
MRSA, and 41.4% had MRSA isolates of SCCmec type
IV, indicative of community-associated MRSA.
In Cox regression, MSSA-colonized participants had
a significantly lower risk for death than did noncolonized
participants in univariate analysis (hazard ratio [HR]
0.82, 95% CI 0.68–0.98) but not after adjustment for covariates. MRSA colonization was associated with higher
risk for death than no S. aureus colonization in univariate analysis (HR 2.40, 95% CI 1.56–3.69) and after adjustment for sociodemographic factors (HR 1.54, 95%
CI 1.06–2.34); MRSA colonization also carried higher
risk for death than MSSA colonization (HR 2.90, 95%
CI 1.92–4.40). However, after additional adjustment for
smoking, body mass index, and co-morbidities (asthma,
diabetes, hypertension, cardiovascular diseases, stroke,
liver disease, and cancer), these associations were no longer significant (Table 2).
Likewise, colonization with SCCmec type II MRSA
more strongly predicted long-term mortality than did
no S. aureus ((HR 3.38, 95% CI 2.00–5.72) or MSSA
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Table 1. Characteristics of study participants by Staphylococcus aureus colonization status, National Health and Nutrition Examination
Survey, United States, 2001–2004*
Characteristic
No S. aureus
MSSA
MRSA
p value† All participants, N = 10,598
Prevalence
71.4
27.3
1.3
100
Median age, y (IQR)
43 (31–56)
41 (30–54)
54 (34–67)
43 (31–55)
Sex
<0.001
M
46.1
54.0
36.4
48.1
F
53.9
46.0
63.6
51.9
Race/ethnicity
<0.001
Non-Hispanic white
70.3
74.4
80.8
71.5
Non-Hispanic black
12.1
8.4
11.7
11.1
Hispanic
12.4
12.8
4.5
12.4
Other
5.2
4.5
3.0
5.0
Body mass index
.28
Normal or underweight
34.6
32.6
33.8
34.0
Overweight or obese
62.4
65.0
63.6
63.2
Missing
3.0
2.4
2.5
2.8
Poverty income ratio
<0.001
<1.85
30.4
29.4
42.7
30.3
>1.85
64.1
64.3
47.7
63.9
Missing
5.5
6.3
0.6
5.8
Smoking
49.2
44.6
63.8
<0.001
48.1
Co-morbidities
Asthma
11.9
12.9
20.5
.07
12.3
Diabetes
8.1
9.4
13.5
.13
8.6
Hypertension
33.0
30.3
39.5
.05
32.4
Cardiovascular diseases‡
6.1
4.6
12.5
.01
5.7
Stroke
2.7
1.9
4.9
.03
2.5
Liver disease
3.4
3.1
2.6
.76
3.3
Cancer
8.9
7.3
16.7
.02
8.5
Hospitalization and/or dialysis in past 12 mo
10.5
10.6
19.8
<0.001
10.6
Mean survival, y (SE)
8.47 (0.11)
8.67 (0.10)
7.5 (0.28)
<0.001
8.52 (0.10)
Death during follow up
9.1
7.7
19.3
<0.001
8.9

*All values are percentages except as indicated. IQR, interquartile range; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin resistant S. aureus.
†p values for comparison of non–S. aureus colonization vs. MRSA colonization vs. MSSA colonization; p values calculated using 2 test for categorical
variables and analysis of variance for continuous variables.
‡Coronary heart disease, congestive heart failure, and myocardial infarction.

colonization (HR 4.05, 95% CI 2.42–6.79) in univariate
analyses but not after adjustment for sociodemographic characteristics. Colonization with SCCmec type IV
MRSA was not associated with death in univariate or
adjusted analysis, unlike no S. aureus or MSSA colonization (Table 2). However, the small number of participants with MRSA SCCmec types II (83) and IV (53)
limited our analysis.
Conclusions
In this population-based study, we found that MSSA is
not associated with long-term mortality. MRSA is associated with risk for death in crude analysis but not after
adjustment for socioeconomic factors, co-morbidities,
or both.
Regarding MSSA, our results are consistent with
studies conducted in inpatient and nursing home participants that also failed to find an association (4–7). Many of
these studies were underpowered, calling for larger scale
investigations. In line with the inverse association in our
unadjusted analysis for MSSA and mortality, Wertheim
et al. found that MSSA-colonized participants had longer survival than did noncolonized participants among

patients with S. aureus bacteremia (3). They suggested
that colonized patients might be more immunologically
adapted to the endogenous S. aureus strains that caused
the bacteremia or that exogenous strains in noncolonized
patients were more virulent. In our case, we hypothesized
that the negative association was imputable to some confounders, such as race/ethnicity, smoking, and co-morbidities (hypertension, cardiovascular diseases, stroke),
instead of an independent association. We found that
persons with MSSA were more likely to be non-Hispanic white and have asthma or diabetes than were persons
without S. aureus nasal carriage, who were more likely be
non-Hispanic black; have a lower poverty income ratio;
be a smoker; and have hypertension, cardiovascular diseases, stroke, liver disease, or cancer. Concerning MRSA,
Chan et al. observed that MRSA colonization was associated with higher mortality than non-MRSA colonization
in nursing home residents in China followed for 2 years
(8). Previous research also found that methicillin resistance in S. aureus bacteremia did not predict long-term
mortality after adjustment for age, comorbidities, severity
of acute illness, metastatic infections, and long-term facility resident status (1).
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Table 2. Cox proportional hazards regression for Staphylococcus aureus colonization and long-term mortality, United States*
Unadjusted
Model 1
Model 2
No.
No.
Exposure variable‡
deaths patients
HR† (95% CI)
p value
HR† (95% CI)§ p value
HR† (95% CI)¶ p value
S. aureus colonization
No S. aureus
1,051
7,794
1 (referent)
1 (referent)
1 (referent)
MSSA
279
2,668
0.82 (0.68–0.98)
0.035
1.03 (0.85–1.24)
0.79
1.06 (0.88–1.27)
0.52
MRSA
41
136
2.40 (1.56–3.69) <0.001
1.54 (1.06–2.34) 0.026
1.38 (0.88–2.17)
0.15
MRSA SCCmec II
36
83
3.38 (2.00–5.72) <0.001
1.42 (0.88–2.26)
0.14
1.40 (0.87–2.24)
0.16
MRSA SCCmec IV
5
53
1.07 (0.37–3.12)
0.9
2.05 (0.60–7.03)
0.25
1.96 (0.55–6.92)
0.29
In colonized participants
MSSA
279
2,668
1 (referent)
1 (referent)
1 (referent)
MRSA
41
136
2.90 (1.92–4.40) <0.001
1.48 (0.94–2.32)
0.09
1.27 (0.76–2.13)
0.35
MRSA SCCmec II
36
83
4.05 (2.42–6.79) <0.001
1.36 (0.84–2.21)
0.2
1.17 (0.66–2.08)
0.58
MRSA SCCmec IV
5
53
1.30 (0.44–3.84)
0.63
1.90 (0.54–6.64)
0.3
1.97 (0.58–6.70)
0.26

*HR, hazard ratio; MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus; SCCmec: staphylococcal cassette chromosome mec.
†Generated by using Cox proportional hazards regression.
‡Categorized into no S. aureus colonization (0), MSSA colonization (1) and MRSA colonization (2), to generate hazard ratios for MSSA colonization (1)
and MRSA colonization (2) in reference to no S. aureus colonization (0). In the analysis by SCCmec types, exposure was categorized into: no S. aureus
colonization (0), MSSA colonization (1), MRSA SCCmec II (2), and MRSA SCCmec IV (3) and hazard ratios for MRSA SCCmec II (2), and MRSA
SCCmec IV were reported. In colonized participants, the analysis was repeated with MSSA colonization being the reference category.
§Adjusted for age, sex, race/ethnicity, and Poverty Income Ratio.
¶Adjusted for age, sex, race/ethnicity, poverty Income ratio, smoking, body mass index, and co-morbidities (asthma, diabetes, hypertension,
cardiovascular diseases, stroke, liver disease, and cancer).

Delayed treatment initiation, virulence factors such
as PVL, or both have been hypothesized to be responsible
for excess mortality in MRSA infections and bacteremia.
Subsequent research found that PVL was associated with
decreased time from colonization to bacteremia but not to
mortality (9). Again in confirmation of our results, Han
et al. studied the effect of SCCmec type on the 30-day inhospital mortality in 184 patients with MRSA and found
SCCmec II significant in univariate analysis, but not after
co-variates adjustment (10). That study also concluded that
SCCmec II was a marker for disease severity instead of a
predictor of mortality.
Our study had several limitations. The carriage of S.
aureus could be transient in some cases and not always
reflect the carriage pattern over time. Although the nares
are the most common site for S. aureus carriage, extranasal
sites can also harbor the organism (11). S. aureus carriage
was tested in 2001–2004 and might not reflect the current
epidemiology and MRSA strain types. Data on co-morbidities, such as cardiovascular or liver diseases and cancer,
were not available for participants 18–19 years of age and
were coded as missing in the analyses. We did not compare death for the genes encoding enterotoxins because of
their limited numbers. However, these NHANES data are
the only national data available, and the major strengths of
our study include the sample size representative of the US
population with generalizable findings and higher power
for statistical inferences.
Our findings are of public health and clinical importance because a lack of independent association between
colonization by S. aureus and mortality implies that decolonization might not prevent death. Some studies indicate that
decolonization of patients at high risk for infections could
reduce the number of subsequent S. aureus infections, but
1968

evidence remains limited that it prevents death (5).

Dr. Mendy is a physician completing a PhD in epidemiology at
the University of Iowa. His research focuses on infectious causes
of chronic diseases.
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